Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Study of MGC028 in Participants With Advanced Solid Tumors [Phase 1]
Clinical trial update for MGC028 in participants with advanced solid tumors. This Phase 1 study is currently recruiting to evaluate safety a…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping
A real-world study is investigating precision treatment for advanced cholangiocarcinoma based on molecular subtyping, and the study has not …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.
A prospective multicenter study of liver transplantation combined with neoadjuvant chemo-radiotherapy for unresectable hilar cholangiocarcin…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
This clinical trial POELH-III evaluates preoperative evaluation of lymph nodes in cholangiocarcinoma and is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories [Phase 4]
Phase 4 study evaluating a Large Channel Digital Pancreaticobiliary Scope (DPS) with compatible accessories is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Volume-Restricted Resection for Perihilar Cholangiocarcinoma
This clinical trial update describes a study on volume-restricted resection for perihilar cholangiocarcinoma. It notes that enrollment has n…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Gavo-cel (TC-210), a mesothelin-targeted therapy, in patients with advanced mesothelin-expressing cancer…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: The Future Management of Patients With Neoplasms of the Gastro-intestinal Tract [NA]
This clinical trial update describes a study on the future management of gastrointestinal tract cancers, including pancreatic adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Effect and Mechanism of ALPPS Operation on Liver Regeneration
This clinical trial update describes evaluating the effects and mechanisms of the ALPPS liver surgery on liver regeneration in patients with…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer [Phase 2]
A Phase 2, single-arm, multicenter exploratory trial is evaluating Adebrelimab plus Apatinib and systemic chemotherapy for initially unresec…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor [Phase 2]
Phase 2 study of TT-00420 (Tinengotinib) in metastatic cholangiocarcinoma patients who failed or relapsed after chemotherapy and FGFR inhibi…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers [NA]
Mayo Clinic is recruiting for a study of Acceptance and Commitment Therapy for reducing cancer-related distress in patients with malignant h…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Improving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically Placed Internal Stents to Prevent Blockage of a Lumen Apposing Metal Stent [NA]
A clinical trial update describes a study comparing two endoscopically placed internal stents to prevent blockage of a lumen-apposing metal …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction
A clinical trial evaluating non-invasive diffusion-weighted imaging with MRCP to diagnose neoplastic biliary obstruction.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma [Phase 2]
A Phase 2 clinical trial is assessing the safety and efficacy of sacituzumab tirumotecan in combination with pucotenlimab for advanced chola…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
A French multicenter observational retrospective study aimed at characterizing rare primary liver cancers, currently recruiting, including s…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) [Phase 2]
A Phase II clinical trial evaluating the combination of durvalumab (PD-L1 inhibitor) and olaparib (PARP inhibitor) in patients with advanced…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Streamlining Radioembolization for CCC and Metastatic Liver Cancer
An ongoing study evaluating streamlined radioembolization approaches for cholangiocarcinoma and metastatic liver cancer (including metastati…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. [Phase 2]
Phase 2 clinical trial evaluating durvalumab with tremelimumab, with or without paclitaxel, for advanced biliary tract cancer after platinum…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer [NA]
This clinical trial update describes the HepQuant study at Montefiore Medical Center evaluating blood-based biomarkers and quantitative MR i…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid [NA]
This document reports that Washington University School of Medicine is implementing a randomized controlled trial to evaluate an expanded we…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Targeted Navigation in Hepatocellular Carcinoma (HCC) [NA]
A University of Miami-sponsored clinical trial is currently recruiting to study targeted navigation approaches in hepatocellular carcinoma, …
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator
A clinical trial registry entry for the Spanish Registry of Direct Cholangiopancreatoscopy by a single operator, sponsored by Germans Trias …